BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15718035)

  • 21. Alzheimer's disease-associated presenilins 1 and 2: accelerated amyloid fibril formation of mutant 410 Cys-->Tyr and 141 Asn-->Ile peptides.
    Maury CP; Nurmiaho-Lassila EL; Liljeström M
    Biochem Biophys Res Commun; 1997 Jun; 235(1):249-52. PubMed ID: 9196071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alzheimer's disease due to presenilin mutations].
    Tabira T
    Nihon Rinsho; 2004 Jan; 62 Suppl():90-4. PubMed ID: 15011327
    [No Abstract]   [Full Text] [Related]  

  • 23. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation.
    Chui DH; Tanahashi H; Ozawa K; Ikeda S; Checler F; Ueda O; Suzuki H; Araki W; Inoue H; Shirotani K; Takahashi K; Gallyas F; Tabira T
    Nat Med; 1999 May; 5(5):560-4. PubMed ID: 10229234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological activity of familial Alzheimer's disease-associated mutant presenilin can be executed by six different gamma-secretase complexes.
    Shirotani K; Tomioka M; Kremmer E; Haass C; Steiner H
    Neurobiol Dis; 2007 Jul; 27(1):102-7. PubMed ID: 17560791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of presenilin function causes Alzheimer's disease-like neurodegeneration in the mouse.
    Chen Q; Nakajima A; Choi SH; Xiong X; Tang YP
    J Neurosci Res; 2008 May; 86(7):1615-25. PubMed ID: 18189321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling clinically heterogeneous presenilin mutations with transgenic Drosophila.
    Seidner GA; Ye Y; Faraday MM; Alvord WG; Fortini ME
    Curr Biol; 2006 May; 16(10):1026-33. PubMed ID: 16713961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New presenilin 1 mutation with Alzheimer disease and Lewy bodies.
    Rosenberg RN
    Arch Neurol; 2005 Dec; 62(12):1808. PubMed ID: 16344337
    [No Abstract]   [Full Text] [Related]  

  • 30. Abnormal intracellular trafficking of high affinity nerve growth factor receptor, Trk, in stable transfectants expressing presenilin 1 protein.
    Hamano T; Mutoh T; Tabira T; Araki W; Kuriyama M; Mihara T; Yano S; Yamamoto H
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):70-6. PubMed ID: 15950763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of AMPA responses by mutated presenilin 1.
    Moerman AM; Barger SW
    J Neurosci Res; 1999 Sep; 57(6):962-7. PubMed ID: 10467268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
    Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
    Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel presenilin-1 mutation (Leu85Pro) in early-onset Alzheimer disease with spastic paraparesis.
    Ataka S; Tomiyama T; Takuma H; Yamashita T; Shimada H; Tsutada T; Kawabata K; Mori H; Miki T
    Arch Neurol; 2004 Nov; 61(11):1773-6. PubMed ID: 15534188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between presenilin-1 Glu318Gly mutation and familial Alzheimer's disease in the Australian population.
    Taddei K; Fisher C; Laws SM; Martins G; Paton A; Clarnette RM; Chung C; Brooks WS; Hallmayer J; Miklossy J; Relkin N; St George-Hyslop PH; Gandy SE; Martins RN
    Mol Psychiatry; 2002; 7(7):776-81. PubMed ID: 12192622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update.
    Raux G; Guyant-Maréchal L; Martin C; Bou J; Penet C; Brice A; Hannequin D; Frebourg T; Campion D
    J Med Genet; 2005 Oct; 42(10):793-5. PubMed ID: 16033913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease.
    Murayama O; Tomita T; Nihonmatsu N; Murayama M; Sun X; Honda T; Iwatsubo T; Takashima A
    Neurosci Lett; 1999 Apr; 265(1):61-3. PubMed ID: 10327206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
    Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
    Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lithium may be useful in the prevention of Alzheimer's disease in individuals at risk of presenile familial Alzheimer's disease.
    Yeh HL; Tsai SJ
    Med Hypotheses; 2008 Dec; 71(6):948-51. PubMed ID: 18760542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease with spastic paresis and cotton wool type plaques.
    Tabira T; Chui DH; Nakayama H; Kuroda S; Shibuya M
    J Neurosci Res; 2002 Nov; 70(3):367-72. PubMed ID: 12391599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of wild type but not an FAD mutant presenilin-1 promotes neurogenesis in the hippocampus of adult mice.
    Wen PH; Shao X; Shao Z; Hof PR; Wisniewski T; Kelley K; Friedrich VL; Ho L; Pasinetti GM; Shioi J; Robakis NK; Elder GA
    Neurobiol Dis; 2002 Jun; 10(1):8-19. PubMed ID: 12079399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.